DIURNAL LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Long-term Safety Study of Chronocort in the Treatment of Participants with Congenital Adrenal Hyperplasia

First Posted Date
2022-03-29
Last Posted Date
2024-11-12
Lead Sponsor
Diurnal Limited
Target Recruit Count
76
Registration Number
NCT05299554
Locations
🇺🇸

Diurnal Investigational Site in California, Orange, California, United States

🇺🇸

Diurnal Investigational Site in Iowa, Iowa City, Iowa, United States

🇺🇸

Diurnal Investigational Site in Florida, Jacksonville, Florida, United States

and more 17 locations

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

First Posted Date
2022-02-03
Last Posted Date
2024-05-14
Lead Sponsor
Diurnal Limited
Target Recruit Count
58
Registration Number
NCT05222152
Locations
🇩🇪

Diurnal Investigational Site in Hamburg, Hamburg, Germany

🇩🇪

Diurnal Investigational Site in Munich, Munich, Germany

🇬🇧

Diurnal Investigational Site in Birmingham, Birmingham, United Kingdom

and more 4 locations

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

Phase 3
Completed
Conditions
Interventions
First Posted Date
2021-10-01
Last Posted Date
2024-03-19
Lead Sponsor
Diurnal Limited
Target Recruit Count
55
Registration Number
NCT05063994
Locations
🇫🇷

Diurnal Investigational Site in Paris, Paris, France

🇺🇸

Diurnal Investigational Site in Maryland, Bethesda, Maryland, United States

🇺🇸

Diurnal Investigational Site in Rochester, Rochester, Minnesota, United States

and more 18 locations

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

First Posted Date
2018-05-22
Last Posted Date
2022-04-08
Lead Sponsor
Diurnal Limited
Registration Number
NCT03532022
Locations
🇺🇸

Diabetes and Endocrinology Consultants PC, Morehead City, North Carolina, United States

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-11-17
Last Posted Date
2020-06-19
Lead Sponsor
Diurnal Limited
Target Recruit Count
25
Registration Number
NCT03343327
Locations
🇬🇧

Simbec Research Ltd., Merthyr Tydfil, United Kingdom

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-10-17
Last Posted Date
2019-10-29
Lead Sponsor
Diurnal Limited
Target Recruit Count
51
Registration Number
NCT03311932
Locations
🇬🇧

Simbec Research Ltd., Merthyr Tydfil, United Kingdom

Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-06-06
Last Posted Date
2017-11-09
Lead Sponsor
Diurnal Limited
Target Recruit Count
19
Registration Number
NCT03178214
Locations
🇬🇧

Simbec Research Ltd., Merthyr Tydfil, United Kingdom

A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH

Phase 3
Completed
Conditions
Interventions
First Posted Date
2017-02-23
Last Posted Date
2024-10-28
Lead Sponsor
Diurnal Limited
Target Recruit Count
91
Registration Number
NCT03062280
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations

First Posted Date
2017-02-14
Last Posted Date
2017-02-14
Lead Sponsor
Diurnal Limited
Target Recruit Count
28
Registration Number
NCT03051893

An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone

First Posted Date
2017-01-12
Last Posted Date
2017-01-12
Lead Sponsor
Diurnal Limited
Target Recruit Count
30
Registration Number
NCT03019614
© Copyright 2024. All Rights Reserved by MedPath